Syft Technologies has been awarded a $3m FRST RFI grant to continue their medical research programme
Syft has again successfully secured a four year grant totaling over $3M dollars from the Foundation for Research Science and Technology’s Research for Industry (RFI) programme.
Syft’s medical strategy director, Dr Jenny Scotter says: “The announcement of this funding is exciting on a number of levels; it will allow us to continue developing our portfolio of medical applications in collaboration with our external research teams including The University of Otago Medical School and the Canterbury DHB, which aligns perfectly with our commercial partnering strategy.”
Syft have also recently been certified under the ISO 13485 quality system, a stringent set of business processes specifically required for the design, manufacture and sale of instrumentation into the lucrative medical diagnostics industry. To date, only a small handful of NZ companies have achieved this exacting quality standard.
Syft Chief Executive Geoff Peck commenting on having achieved certification said: "For a small and growing company, having robust business practices across the company is a vital component in our journey towards FDA approval and subsequent success in the medical sector. Our ability to reach the standards set out by ISO 13485 is testament to the quality of our team, their research and our processes."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
